SLR Investment Corp. operates as a specialized investment firm, providing diverse capital solutions to leveraged middle-market businesses. The company's primary focus involves secured credit facilities, encompassing first-lien unitranche and second-lien debt, alongside junior (unsecured) debt instruments and minority equity investments. It actively participates in various corporate finance activities, including leveraged buyouts, strategic acquisitions, balance sheet recapitalizations, growth capital infusions, and general refinancing; on occasion, it also pursues strategic, income-oriented control equity positions. The firm's investment scope spans a highly diversified array of sectors such as aerospace, manufacturing, financial services, consumer goods, technology, media, and utilities, among many others. Additionally, it maintains a specialized emphasis on the life sciences, specifically targeting opportunities within specialty pharmaceuticals, medical devices, biotechnology, healthcare providers, and health technology. SLR Investment Corp. predominantly allocates its capital within the United States. Individual investment commitments typically fall between $5 million and $100 million. It targets companies with annual revenues ranging from $50 million to $1 billion and EBITDA figures between $15 million and $100 million. The company utilizes various financial instruments, including senior secured loans, mezzanine debt, and equity securities. While its equity investments are generally non-controlling, it also explores opportunities in thinly traded public companies and secondary market transactions. The firm generally aims to exit its investments within three years of the initial capital deployment.